

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in the understanding and management... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-575/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-575" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations.">
            <meta name="og:description" content="Read the latest article version by Kate Skolnik, Bradley S. Quon, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="15139">
            <meta name="article-id" content="13926">
            <meta name="dc.title" content="Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations">
            <meta name="dc.description" content="Pulmonary exacerbations are common events in cystic fibrosis and have a profound impact on quality of life, morbidity, and mortality. Pulmonary exacerbation outcomes remain poor and a significant proportion of patients fail to recover their baseline lung function despite receiving aggressive treatment with intravenous antibiotics. This focused review provides an update on some of the recent advances that have taken place in our understanding of the epidemiology, pathophysiology, diagnosis, and management of pulmonary exacerbations in cystic fibrosis as well as direction for future study.">
            <meta name="dc.subject" content="cystic fibrosis, exacerbations, treatment">
            <meta name="dc.creator" content="Skolnik, Kate">
            <meta name="dc.creator" content="Quon, Bradley S.">
            <meta name="dc.date" content="2018/05/14">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.13926.1">
            <meta name="dc.source" content="F1000Research 2018 7:575">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="cystic fibrosis">
            <meta name="prism.keyword" content="exacerbations">
            <meta name="prism.keyword" content="treatment">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/05/14">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="575">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.13926.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-575">
            <meta name="citation_title" content="Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations">
            <meta name="citation_abstract" content="Pulmonary exacerbations are common events in cystic fibrosis and have a profound impact on quality of life, morbidity, and mortality. Pulmonary exacerbation outcomes remain poor and a significant proportion of patients fail to recover their baseline lung function despite receiving aggressive treatment with intravenous antibiotics. This focused review provides an update on some of the recent advances that have taken place in our understanding of the epidemiology, pathophysiology, diagnosis, and management of pulmonary exacerbations in cystic fibrosis as well as direction for future study.">
            <meta name="citation_description" content="Pulmonary exacerbations are common events in cystic fibrosis and have a profound impact on quality of life, morbidity, and mortality. Pulmonary exacerbation outcomes remain poor and a significant proportion of patients fail to recover their baseline lung function despite receiving aggressive treatment with intravenous antibiotics. This focused review provides an update on some of the recent advances that have taken place in our understanding of the epidemiology, pathophysiology, diagnosis, and management of pulmonary exacerbations in cystic fibrosis as well as direction for future study.">
            <meta name="citation_keywords" content="cystic fibrosis, exacerbations, treatment">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Kate Skolnik">
            <meta name="citation_author_institution" content="Division of Respirology, Department of Medicine, University of Calgary, Calgary, AB, Canada">
            <meta name="citation_author" content="Bradley S. Quon">
            <meta name="citation_author_institution" content="Centre for Heart Lung Innovation, St Paul&rsquo;s Hospital, Department of Medicine, University of British Columbia, Vancouver, BC, Canada">
            <meta name="citation_publication_date" content="2018/05/14">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="575">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.13926.1">
            <meta name="citation_firstpage" content="575">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-575/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-575.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=15139 /> <input type=hidden id=articleId name=articleId value=13926 /> <input type=hidden id=xmlUrl value="/articles/7-575/v1/xml"/> <input type=hidden id=xmlFileName value="-7-575-v1.xml"> <input type=hidden id=article_uuid value=ec0a8c35-f7b2-457c-81d1-c31c651223fa /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.13926.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.13926.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-575"
  },
  "headline": "Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations",
  "datePublished": "2018-05-14T16:05:14",
  "dateModified": "2018-05-14T16:05:14",
  "author": [
    {
      "@type": "Person",
      "name": "Kate Skolnik"
    },    {
      "@type": "Person",
      "name": "Bradley S. Quon"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Pulmonary exacerbations are common events in cystic fibrosis and have a profound impact on quality of life, morbidity, and mortality. Pulmonary exacerbation outcomes remain poor and a significant proportion of patients fail to recover their baseline lung function despite receiving aggressive treatment with intravenous antibiotics. This focused review provides an update on some of the recent advances that have taken place in our understanding of the epidemiology, pathophysiology, diagnosis, and management of pulmonary exacerbations in cystic fibrosis as well as direction for future study."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-575.html",
            "name": "Recent advances in the understanding and management of cystic fibrosis..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in the understanding and management of cystic fibrosis... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=15139 data-id=13926 data-downloads="" data-views="" data-scholar="10.12688/f1000research.13926.1" data-recommended="" data-doi="10.12688/f1000research.13926.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-575/v1/pdf?article_uuid=ec0a8c35-f7b2-457c-81d1-c31c651223fa" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-13926-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-13926-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-13926-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Skolnik K and Quon BS. Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):575 (<a class=new-orange href="https://doi.org/10.12688/f1000research.13926.1" target=_blank>https://doi.org/10.12688/f1000research.13926.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-13926-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=13926 id=track-article-signin-13926 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/13926?target=/articles/7-575.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=15139 /> <input name=articleId type=hidden value=13926 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations</h1><span class=other-info> [version 1; peer review: 3 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Kate Skolnik<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:Bradley.Quon@hli.ubc.ca" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Bradley S. Quon</span></a><a href="https://orcid.org/0000-0003-1785-3870" target=_blank id=author-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-1785-3870</div><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Kate Skolnik<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:Bradley.Quon@hli.ubc.ca" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Bradley S. Quon</span></a><a href="http://orcid.org/0000-0003-1785-3870" target=_blank id=mauthor-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-1785-3870</div><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 14 May 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.13926.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Division of Respirology, Department of Medicine, University of Calgary, Calgary, AB, Canada<br/> <sup>2</sup> Centre for Heart Lung Innovation, St Paul&rsquo;s Hospital, Department of Medicine, University of British Columbia, Vancouver, BC, Canada<br/> <p> <div class=margin-bottom> Kate Skolnik <br/> <span>Roles: </span> Conceptualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Bradley S. Quon <br/> <span>Roles: </span> Conceptualization, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=34269-33849></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=34268-33847></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=28992-33850></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Pulmonary exacerbations are common events in cystic fibrosis and have a profound impact on quality of life, morbidity, and mortality. Pulmonary exacerbation outcomes remain poor and a significant proportion of patients fail to recover their baseline lung function despite receiving aggressive treatment with intravenous antibiotics. This focused review provides an update on some of the recent advances that have taken place in our understanding of the epidemiology, pathophysiology, diagnosis, and management of pulmonary exacerbations in cystic fibrosis as well as direction for future study. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> cystic fibrosis, exacerbations, treatment </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Bradley S. Quon (<a href="mailto:Bradley.Quon@hli.ubc.ca">Bradley.Quon@hli.ubc.ca</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Bradley S. Quon </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> BSQ receives salary support from the Michael Smith Foundation for Health Research and from Cystic Fibrosis Canada. <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2018 Skolnik K and Quon BS. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Skolnik K and Quon BS. Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):575 (<a href="https://doi.org/10.12688/f1000research.13926.1" target=_blank>https://doi.org/10.12688/f1000research.13926.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 14 May 2018, <b>7</b>(F1000 Faculty Rev):575 (<a href="https://doi.org/10.12688/f1000research.13926.1" target=_blank>https://doi.org/10.12688/f1000research.13926.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 14 May 2018, <b>7</b>(F1000 Faculty Rev):575 (<a href="https://doi.org/10.12688/f1000research.13926.1" target=_blank>https://doi.org/10.12688/f1000research.13926.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d2492e165>Introduction</h2><p class="" id=d2492e168>Despite improvements in lung function and nutritional outcomes for individuals with cystic fibrosis (CF) over the past decade, pulmonary exacerbation (PEx) remains common. In 2016, according to US Cystic Fibrosis Foundation Patient Registry data, one in three patients required at least one course of intravenous (IV) antibiotics to treat a PEx<sup><a href="#ref-1">1</a></sup>. Exacerbations have a profound impact on the morbidity and quality of life of individuals with CF, and unfortunately PEx outcomes remain suboptimal with poor recovery of baseline lung function following PEx treatment<sup><a href="#ref-2">2</a></sup>. As a result, efforts are under way within the CF research community to improve the management of these clinically impactful events. The focus of this review is to summarize some of the recent advances that have taken place in our understanding of the epidemiology, pathophysiology, diagnosis, and management of PEx in CF and to provide direction for future study.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d2492e182>Pulmonary exacerbation definition and diagnosis</h2><p class="" id=d2492e185>Although there is general agreement on the importance of PEx, there is no consensus definition of what constitutes a PEx by CF clinicians, researchers, and the broader CF community. However, an ideal or consensus PEx definition (or scoring system) is likely to remain elusive without a gold standard to compare it against. Varying PEx definitions employed in the CF literature have been a major impediment to research progress and have inherently confounded many of the studies included in this review. This caveat must be kept in mind while reading this review because of the potential lack of specificity about what is being studied and discussed.</p><p class="" id=d2492e188>In an attempt to move toward a consensus PEx definition, the EuroCFCare Working group has recommended the use of a modified Fuchs criteria to define a PEx which includes the need for additional antibiotic treatment (oral or IV) and a recent change of at least two of the following six criteria: change in sputum volume or color; increased cough; increased fatigue, malaise, or lethargy; anorexia or weight loss; decrease in pulmonary function by 10% or more or radiographic changes; and increased dyspnea<sup><a href="#ref-3">3</a></sup>. However, this definition has been criticized by some experts in the field because the diagnosis of PEx should be independent of the physician’s decision to treat and pulmonary function testing limits the age range of patients assessed. Some recent pediatric trials have used the PEx definition employed in the Early <i>Pseudomonas</i> Infection Control (EPIC) trial, which consists of one major criterion (decrease in forced expiratory volume in one second [FEV<sub>1</sub>] at least 10% from baseline with the previous 6 months; oxygen saturation less than 90% on room air or at least 5% decline from baseline; new lobar infiltrates or atelectasis on chest X-ray; hemoptysis) or two minor symptoms/signs (increased respiratory rate; new or increased adventitial sounds on lung exam; weight loss of at least 5% in the previous 6 months; increased cough; decreased exercise tolerance; increased chest congestion or change in sputum) for at least 5 days or with significant symptom severity<sup><a href="#ref-4">4</a></sup>.</p><p class="" id=d2492e205>Despite the lack of a consensus PEx definition, recent studies have focused on strategies to diagnose CF PEx earlier given the risk of poor outcomes. In the Standardized Treatment of Pulmonary Exacerbations (STOP) study, a multi-site observational study of patients with CF treated with IV antibiotics in hospital, most patients (85%) described symptoms more than 7 days before admission and nearly one-third (32%) had symptoms more than 21 days beforehand<sup><a href="#ref-5">5</a></sup>. Less than half (48%) of these individuals received oral antibiotics prior to admission, suggesting that certain patients may have prolonged symptoms in keeping with PEx but, due to delays in diagnosis, are not started on treatment. For these reasons, there has been a recent focus on home monitoring of symptoms and lung function to promote earlier PEx detection and treatment to prevent irreversible lung damage.</p><p class="" id=d2492e212>A multi-center study from the Netherlands examining electronic home monitoring of symptoms and lung function for early PEx detection confirmed a change in symptoms at least 4 weeks prior to PEx diagnosis in most patients, and further symptom deterioration in the 2 weeks prior to PEx diagnosis<sup><a href="#ref-6">6</a></sup>. However, a large multi-center randomized trial recently conducted in the US demonstrated that although electronic home monitoring of symptoms and spirometry is feasible and leads to earlier and more frequent diagnoses of PEx compared with usual care, this strategy does not lead to less lung function lost over 1 year<sup><a href="#ref-7">7</a></sup>. An earlier diagnosis in the home-monitoring arm led to more frequent use of oral (versus IV) antibiotics compared with the usual-care arm (67% versus 43%), and this might have resulted in a higher rate of non-recovery of FEV<sub>1</sub> % predicted to within 5% of baseline (47% versus 21%) due to a less robust response to oral antibiotic treatment<sup><a href="#ref-7">7</a></sup>. The authors concluded that identifying PEx earlier may not be sufficient and that future studies must also find better approaches to treatment of exacerbations once they are detected. However, there may still be utility for home monitoring for early PEx detection, particularly for individuals who are poor perceivers of their symptoms, have frequent exacerbations, or reside in rural areas which may delay access to care.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d2492e233>Pulmonary exacerbation epidemiology</h2><div class=section><a name=d2492e236 class=n-a></a><h3 class=section-title>Pulmonary exacerbation prevalence</h3><p class="" id=d2492e241>The proportion of patients requiring at least one course of IV antibiotics per year has not decreased significantly over the past decade<sup><a href="#ref-1">1</a></sup>. Although this might seem concerning in light of the overall improvements in lung function observed over the same time period, this appears to be driven by a lower threshold among clinicians to diagnose and treat PEx<sup><a href="#ref-8">8</a></sup>. Some important studies have highlighted the wide variability in the recognition and treatment of PEx between CF clinics and individual CF physicians in both the US and the UK<sup><a href="#ref-9">9</a>,<a href="#ref-10">10</a></sup>. A multi-center study in the UK demonstrated higher IV antibiotic use among centers with higher baseline FEV<sub>1</sub> % predicted<sup><a href="#ref-10">10</a></sup>, whereas an older multi-center US study found variability among centers with respect to care (those with a higher median FEV<sub>1</sub> % predicted had more frequent monitoring and antibiotics)<sup><a href="#ref-9">9</a></sup>. These findings have led to quality improvement initiatives to reduce variability<sup><a href="#ref-11">11</a>,<a href="#ref-12">12</a></sup>.</p></div><div class=section><a name=d2492e282 class=n-a></a><h3 class=section-title>Pulmonary exacerbation risk factors</h3><p class="" id=d2492e287>In order to prevent PEx and their associated sequelae, there has been a great deal of interest in identifying the risk factors for future PEx. VanDevanter <i>et al</i>. investigated factors associated with increased risk of PEx requiring IV antibiotics<sup><a href="#ref-13">13</a></sup>. The study found that, out of numerous clinical variables, including sputum microbiology and treatment characteristics, the strongest risk factor for a PEx requiring IV antibiotic therapy was the occurrence of a PEx requiring IV antibiotics in the preceding year<sup><a href="#ref-13">13</a></sup>. Not surprisingly, individuals with three or more exacerbations had the highest risk of future PEx compared with those with one or two exacerbations<sup><a href="#ref-13">13</a></sup>.</p></div><div class=section><a name=d2492e306 class=n-a></a><h3 class=section-title>Pulmonary exacerbation outcomes</h3><p class="" id=d2492e311>With regard to PEx treatment outcomes, exacerbations treated with oral antibiotics are often considered to be milder events, whereas those treated with IV antibiotics are considered to represent more severe events. However, labeling a PEx on the basis of route of antibiotic treatment (oral versus IV) is limited and potentially biased, since factors other than PEx severity (based on symptoms, inflammatory markers, or lung function decline or a combination of these) may influence the decision of antibiotic route. For instance, IV antibiotics may be chosen on the basis of medication allergies/intolerances, bacterial resistance to oral antibiotics, or other non-disease severity-related factors (such as psychosocial issues or insurance coverage).</p><p class="" id=d2492e314>In support of the concept that exacerbations treated with oral antibiotics may not represent mild events, based on a recent retrospective study using the Toronto CF database from 2000 to 2014, nearly 20% of exacerbations treated with oral antibiotics did not recover to within 90% of baseline FEV<sub>1</sub> % predicted within 3 months of treatment<sup><a href="#ref-14">14</a></sup>. Furthermore, the greater the number of cumulative oral antibiotic-treated events over the study period, the steeper the rate of lung function decline<sup><a href="#ref-14">14</a></sup>. Consequently, close follow-up post-treatment is warranted to ensure recovery, and patients with repeated exacerbations treated with oral antibiotics may warrant more intensive treatment with IV antibiotics.</p><p class="" id=d2492e328>Even among patients who receive aggressive treatment with IV antibiotics, PEx outcomes remain suboptimal. Based on CF registry data from both the US and Canada, 25% of individuals who experience exacerbations fail to recover baseline lung function as defined by 90% of baseline within 3 months of treatment<sup><a href="#ref-2">2</a>,<a href="#ref-15">15</a></sup>. Factors independently associated with non-response included female sex; malnourishment; pancreatic insufficiency; persistent infection with <i>Pseudomonas aeruginosa</i>, <i>Burkholderia cepacia</i> complex, or methicillin-resistant <i>Staphylococcus aureus</i>; allergic bronchopulmonary aspergillosis; larger drop in FEV<sub>1</sub> % predicted at the time of PEx; and longer time from baseline spirometric assessment<sup><a href="#ref-2">2</a></sup>.</p><p class="" id=d2492e355>It is important to recognize that the proportion of non-responders can vary substantially depending on the definition of “response” used. For example, when a definition of FEV<sub>1</sub> improvement to 90% of baseline is employed, 25% of exacerbations are classified as non-responders, whereas an improvement to 100% of baseline yields a non-response rate as high as 60%<sup><a href="#ref-16">16</a></sup>. Furthermore, it should be noted that up to 25% of patients in the STOP trial had their best lung function at the time of PEx diagnosis and therefore a sizeable proportion of patients will be defined as responders even before treatment has started, leading to underestimation of treatment non-response. Most studies have used the best FEV<sub>1</sub> in the 3 months following the end of IV antibiotic treatment as the follow-up FEV<sub>1</sub>, since lung function improvement can continue following the completion of IV antibiotics and therefore end-of-treatment values can underestimate rates of response.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d2492e375>Pulmonary exacerbation triggers</h2><p class="" id=d2492e378>Viral respiratory tract infections have been estimated to be associated with about 50% of exacerbations and this might explain why exacerbations are more frequent during the winter months<sup><a href="#ref-17">17</a>–<a href="#ref-19">19</a></sup>. The most common viral pathogens include rhinovirus, respiratory syncytial virus (RSV) (in children), parainfluenza, influenza, adenovirus, coronavirus, and coxsackie/echovirus<sup><a href="#ref-17">17</a>,<a href="#ref-18">18</a>,<a href="#ref-20">20</a>,<a href="#ref-21">21</a></sup>. It was previously hypothesized that viruses could increase bacterial density of chronic colonizing organisms; however, a recent study has refuted this, demonstrating no change in <i>P. aeruginosa</i> density between viral- versus non-viral-associated PEx<sup><a href="#ref-17">17</a></sup>. Interestingly, anti-viral interferon signaling in response to RSV infection is capable of inducing <i>P. aeruginosa</i> biofilm formation through dysregulated iron homeostasis and this could represent a putative mechanism for viral-triggered PEx but warrants further study<sup><a href="#ref-22">22</a></sup>. It is also important to note that although there appears to be a strong association between viruses and PEx, this does not necessarily imply a causal relationship, as studies have demonstrated the presence of virus even when patients are well (suggesting asymptomatic nasopharyngeal carriage)<sup><a href="#ref-23">23</a>,<a href="#ref-24">24</a></sup>.</p><p class="" id=d2492e423>While non-viral-associated exacerbations were also believed to be the result of increased bacterial density of the chronic primary pathogen, recent studies have challenged this dogma. Multiple studies have demonstrated no significant changes in bacterial density from stable to PEx state<sup><a href="#ref-25">25</a>–<a href="#ref-28">28</a></sup>. Although decreases in bacterial density are observed following anti-microbial treatment, these effects are transient and are poorly predictive of clinical response<sup><a href="#ref-28">28</a>–<a href="#ref-30">30</a></sup>. Research has shown that CF airway infections are polymicrobial and that interactions between these microbes may increase or decrease pathogenicity<sup><a href="#ref-31">31</a></sup>. It is believed by some experts that organisms (such as anaerobes) can interact with the primary pathogen to enhance virulence without a change in density<sup><a href="#ref-31">31</a></sup>. For example, a recent study evaluating airway bacterial communities with 16S rRNA sequencing found no significant differences in bacterial community diversity or density between paired stable and PEx samples, but there was a change in community structure for a subgroup of patients<sup><a href="#ref-26">26</a></sup>. Furthermore, the absolute and relative abundance of <i>Gemella spp</i>. increased in the majority of samples from stable to PEx state, and this was most discriminative of health status (stable versus PEx)<sup><a href="#ref-26">26</a></sup>.</p><p class="" id=d2492e460>Air pollution is also an important trigger of PEx, and a seminal study linking the US CF National Registry to the US Environmental Protection Agency Aerometric Information Retrieval System demonstrated a significant association between annual average exposure to particulate matter and risk of PEx<sup><a href="#ref-32">32</a></sup>. A recent case-crossover analysis confirmed this finding and found that increased exposure to particulate matter less than 10 mm in diameter (PM<sub>10</sub>), nitrogen dioxide, and ozone was associated with increased need for oral or IV antibiotics for PEx on the day of exposure<sup><a href="#ref-33">33</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d2492e477>Pulmonary exacerbation treatment</h2><div class=section><a name=d2492e480 class=n-a></a><h3 class=section-title>Treatment endpoints</h3><p class="" id=d2492e485>In general, the goal of PEx treatment is to improve symptoms and recover lost lung function<sup><a href="#ref-34">34</a></sup>. Based on the STOP study, physicians identified recovery of lung function as the primary objective of treatment in 53% of exacerbations compared with improvement of symptoms in 43% of exacerbations<sup><a href="#ref-5">5</a></sup>. There is considerable variability as to what constitutes an acceptable threshold for FEV<sub>1</sub> improvement before antibiotics can be stopped. Based on the STOP study, the mean FEV<sub>1</sub> improvement was 9% (standard deviation [SD] 10%) predicted at the end of IV antibiotic treatment and 7% (SD 11%) predicted at day 28. Patients with baseline FEV<sub>1</sub> of more than 50% predicted had a greater increase in FEV<sub>1</sub> % predicted from admission to day 28 than patients with baseline FEV<sub>1</sub> less than 50% predicted (10% versus 3%). Interestingly, there was discordance between physician treatment targets in terms of lung function improvement and evaluation of treatment success. Based on the STOP study, 84% of clinicians deemed PEx treatment successful, although only 61% of patients achieved at least 90% of their target FEV<sub>1</sub> by the end of IV antibiotic therapy<sup><a href="#ref-35">35</a></sup>.</p><p class="" id=d2492e519>The treatment endpoint for an individual patient is likely to depend on the primary motivating factor for treatment. In the STOP study, a significant proportion of patients (20%) were admitted for IV antibiotics despite presenting with their best recorded FEV<sub>1</sub> % predicted in the prior 6 months<sup><a href="#ref-5">5</a></sup>. In these cases, symptoms were the primary driver for treatment and symptom resolution would be the most appropriate endpoint of treatment response. In general, exacerbations are more likely to be defined based on symptoms alone in children compared with adults (in whom drop in lung function may be more likely to occur)<sup><a href="#ref-36">36</a></sup>. The most widely used daily scoring system for monitoring of respiratory/infectious symptoms during PEx treatment is the Cystic Fibrosis Respiratory Symptom Diary – Chronic Respiratory Infection Symptom Score (CFRSD-CRISS)<sup><a href="#ref-37">37</a></sup>. Total scores range from 0 to 100, and an 11-point decrease is considered clinically significant<sup><a href="#ref-38">38</a></sup>. Based on STOP, CFRSD-CRISS decreased by 26.1 (95% confidence interval 23.8–28.3) and 83% of patients achieved a clinically significant improvement<sup><a href="#ref-35">35</a></sup>. However, it should be noted that the CFRSD-CRISS has limitations in that it has been used and evaluated in a research setting only and has not been accepted by the US Food and Drug Administration as a validated endpoint.</p><p class="" id=d2492e546>Whereas short-term goals of PEx treatment are to recover lost lung function and improve symptoms, long-term treatment goals generally are to prevent recurrent events and reduce the rate of lung function decline. Interestingly, a recent study found that symptom improvement (that is, CFRSD-CRISS score) in response to PEx treatment is poorly predictive of long-term response in terms of recovery of baseline lung function at 3 months or time to next IV antibiotics; however, immediate FEV<sub>1</sub> response (&gt;10% relative improvement) was predictive of recovery of baseline FEV<sub>1</sub> by 3 months<sup><a href="#ref-39">39</a></sup>. Synthesizing all of this evidence suggests that a composite outcome that includes symptom and lung function improvement might be the most appropriate endpoint in prospective studies examining PEx therapies.</p></div><div class=section><a name=d2492e560 class=n-a></a><h3 class=section-title>Treatment controversies</h3><p class="" id=d2492e565>Based on the 2009 Cystic Fibrosis Foundation PEx treatment guidelines, there was insufficient evidence to provide recommendations on a number of decisions related to PEx management, including site of treatment (inpatient versus outpatient), antibiotic duration, and the use of adjunctive therapies (such as systemic steroids) (<a href="#f1">Figure 1</a>)<sup><a href="#ref-40">40</a></sup>. Since this publication, observational studies have provided additional insights into these treatment controversies and randomized controlled trials (RCTs) are ongoing or have been recently completed.</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/15139/f4b529e7-82e4-4f56-88ce-4a0988963697_figure1.gif"><img alt="f4b529e7-82e4-4f56-88ce-4a0988963697_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/15139/f4b529e7-82e4-4f56-88ce-4a0988963697_figure1.gif"></a><div class=caption><h3>Figure 1. Outline of pulmonary exacerbation treatment decisions.</h3><p id=d2492e585>CBC, complete blood count; CFRSD-CRISS, Cystic Fibrosis Respiratory Symptom Diary-Chronic Respiratory Infection Symptom Score; Cr, creatinine; CRP, C-reactive protein; C+S, culture and sensitivity; IV, intravenous; LFT, liver function test; PEx, pulmonary exacerbation.</p></div></div></div><div class=section><a name=d2492e593 class=n-a></a><h3 class=section-title>Site of treatment</h3><p class="" id=d2492e598>There are some circumstances in which admission to hospital for optimal PEx treatment is clearly indicated (such as hypoxia, complications such as pneumothorax, or co-morbidities such as renal failure), but in many situations outpatient treatment with IV antibiotics appears to be a reasonable option. However, in deciding on the optimal treatment setting, an important factor is not just safety and feasibility but also whether one treatment setting is more efficacious than the other. One small randomized, two-factor, mixed-design comparative study involving 17 adults with CF has been performed and showed similar results for most outcome measures for home and hospital treatment<sup><a href="#ref-41">41</a></sup>. Owing to selection bias, the results of a larger RCT of the two treatment settings may not be generalizable and will be challenging to interpret because of lack of blinding, attrition bias, high rates of crossover, and lack of standardized resources for home care at various care centers<sup><a href="#ref-40">40</a></sup>.</p><p class="" id=d2492e609>A small, single-center retrospective study examined 143 PEx events from 50 patients and compared hospital with home IV therapy<sup><a href="#ref-42">42</a></sup>. The baseline characteristics between the two groups were similar; however, the hospitalized group had a greater improvement in lung function with a shorter duration of therapy<sup><a href="#ref-42">42</a></sup>. In a recent observational study of pediatric CF patients from the Epidemiologic Study of CF (ESCF), those with an acute decline in lung function were more likely to recover to within 90% of baseline FEV<sub>1</sub> when receiving treatment as an inpatient versus outpatient<sup><a href="#ref-43">43</a></sup>. However, observational studies involving treatment are often confounded by indication bias. In other words, patients are not randomly assigned and therefore the intensity of treatments is not standardized between comparisons; ultimately, patients in hospital might receive more intensive treatments. Another recent study that also used the ESCF employed statistical approaches to control for indication bias and found that PEx with a greater proportion of days treated as an inpatient (versus outpatient) with IV antibiotics was more likely to lead to return of FEV<sub>1</sub> % predicted to at least 90% of baseline<sup><a href="#ref-44">44</a></sup>. Although this observational study is not definitive (as there was likely residual confounding), the benefits of inpatient PEx treatment are likely due to multiple factors other than the IV antibiotics alone, including improved medication adherence, better nutrition, real-time adjustment of adjunct therapies, increased airway clearance treatments, and increased rest.</p><p class="" id=d2492e635>Ultimately, the decision regarding treatment site should be made based on careful consideration of patient factors (with a low threshold for inpatient treatment if there are concerns about patient reliability and adherence to airway clearance therapies, sufficient home supports, or more complex IV antibiotic regimens)<sup><a href="#ref-40">40</a></sup>.</p></div><div class=section><a name=d2492e643 class=n-a></a><h3 class=section-title>Duration of antibiotics</h3><p class="" id=d2492e648>For historical reasons, CF exacerbations are typically treated for 14 days. Based on the STOP study, the mean duration of treatment was 15.9 (SD 6.0) days; however, 11% of patients received treatment for 10 days or less and 60% received treatment for more than 14 days with no significant differences in duration for individuals younger than 18 years old versus those older than 18 years old<sup><a href="#ref-35">35</a></sup>. There have been no randomized studies examining the duration of IV antibiotics to provide evidence-based recommendations. An observational study that used the US CF Foundation Patient Registry found that FEV<sub>1</sub> % predicted plateaus by day 10 of treatment and duration of treatment did not influence time until next PEx<sup><a href="#ref-45">45</a></sup>. More recent retrospective data on the benefits of prolonging antibiotic treatment are conflicting, as a study using the Toronto CF Database found improved outcomes with longer treatment duration (&gt;14 days) whereas a larger study using data from the ESCF did not find a significant association between treatment duration and rate of recovery of FEV<sub>1</sub> % predicted to within 90% of baseline<sup><a href="#ref-16">16</a>,<a href="#ref-44">44</a></sup>. However, as in observational studies of treatment setting, interpretation is limited by indication bias, since patient factors influence treatment duration (patients with lower lung function received longer treatment courses)<sup><a href="#ref-45">45</a></sup>. A large multi-center study (STOP2) is under way in the US examining IV antibiotic duration since it was identified as the most important research question by CF physicians and patients/caregivers. A divergent trial design is being used and randomly assigns patients to 10 versus 14 days or 14 versus 21 days of IV antibiotics depending on initial symptom and lung function response by day 7<sup><a href="#ref-46">46</a></sup>.</p></div><div class=section><a name=d2492e683 class=n-a></a><h3 class=section-title>Adjunctive therapies</h3><p class="" id=d2492e688>A recent study evaluating inpatient PEx treatment practices for pediatric CF patients across the US demonstrated wide variability in the use of adjunctive treatments, including hypertonic saline, azithromycin, and systemic corticosteroids<sup><a href="#ref-47">47</a></sup>. Several adjunct therapies for the treatment of CF PEx have recently been evaluated or are currently under investigation. These adjunct therapies function by either optimizing airway clearance or reducing airway inflammation.</p><p class="" id=d2492e695>Although nebulized hypertonic saline is well established as a strategy for PEx prevention<sup><a href="#ref-48">48</a></sup>, it has only recently been studied as an adjunct during PEx treatment. In an RCT, Dentice <i>et al</i>. compared PEx outcomes in individuals randomly assigned to nebulized 7% hypertonic saline versus taste-masked control thrice daily<sup><a href="#ref-49">49</a></sup>. The majority of patients in both groups had either never or only intermittently used hypertonic saline prior to enrollment. Although this study did not meet its primary endpoint in terms of reduced length of hospital stay, there was greater improvement in symptoms and higher rates of FEV<sub>1</sub> recovery in the hypertonic saline group<sup><a href="#ref-49">49</a></sup>. Furthermore, the study provided reassurance that nebulized hypertonic saline was safe to start (or increase) in the context of acute PEx<sup><a href="#ref-49">49</a></sup>.</p><p class="" id=d2492e721>Another recent study examined doxycycline as an adjunct therapy for CF PEx, acting as a small-molecule inhibitor of matrix metalloproteinase-9 (MMP-9), which has been implicated in CF airway pathophysiology, particularly during PEx<sup><a href="#ref-50">50</a>,<a href="#ref-51">51</a></sup>. This single-center RCT randomly assigned 39 CF patients with PEx requiring inpatient care to either doxycycline 100 mg orally twice daily or placebo for 8 days in addition to standard patient care (IV antibiotics and increased airway clearance)<sup><a href="#ref-52">52</a></sup>. Compared with the placebo group, the doxycycline group had a significant decrease in total and active sputum MMP-9 levels, improved protease-antiprotease imbalance in the airways, greater improvement in FEV<sub>1</sub> % predicted from admission, and longer time to next PEx<sup><a href="#ref-52">52</a></sup>. Whether doxycycline has direct effects on dysregulated protease activity versus indirect effects due to changes in the microbiome remains unclear, but this single-center study has set the stage for a larger multi-center placebo-controlled RCT<sup><a href="#ref-52">52</a></sup>.</p><p class="" id=d2492e746>Although systemic corticosteroids are used in up to 20% of CF exacerbations<sup><a href="#ref-35">35</a>,<a href="#ref-39">39</a></sup>, there is limited evidence to support their use<sup><a href="#ref-40">40</a></sup>. Just one small pilot placebo-controlled study involving 24 patients (≥10 years old) examined oral prednisone (2 mg/kg per day up to a maximum of 60 mg divided twice daily) versus placebo for the first 5 days as an adjunct to standard-of-care PEx treatment<sup><a href="#ref-53">53</a></sup>. Although there was no significant effect on lung function, symptom improvement, or sputum inflammatory markers compared with placebo, the study was underpowered to evaluate treatment effects<sup><a href="#ref-53">53</a></sup>. A multi-center, randomized, placebo-controlled trial evaluating prednisone—referred to as the Prednisone in CF Pulmonary Exacerbation (PIPE) study—is under way and involves six pediatric and adult CF clinics across Canada. This study will provide more definitive evidence regarding the role of systemic corticosteroids during PEx. Patients receiving IV antibiotic treatment and who have not responded to standard of care alone by day 7 (that is, not recovered at least 90% of their baseline FEV<sub>1</sub> % predicted) will be randomly assigned to prednisone (2 mg/kg per day up to a maximum of 60 mg divided twice daily) or placebo for 7 days.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d2492e776>Pulmonary exacerbation biomarkers</h2><p class="" id=d2492e779>In the field of CF, there is tremendous interest in identifying a biomarker that could aid in the earlier diagnosis of a CF PEx or assist in tracking the response to PEx treatment or do both. Earlier diagnosis can allow for the timelier initiation of treatment, which might result in better PEx outcomes. A reliable biomarker of response to treatment could also identify non-responders earlier during the course of treatment so that therapies can be modified or extended accordingly.</p><p class="" id=d2492e782>The majority of biomarkers in relation to PEx have focused on inflammation in the sputum and blood<sup><a href="#ref-54">54</a>,<a href="#ref-55">55</a></sup>. Although sputum is an attractive option because it most closely reflects airway inflammation, its evaluation has been limited to research studies because it can be challenging to collect and process in clinical laboratories. Several sputum biomarkers of inflammation, including interleukin-8 (IL-8), neutrophil elastase (NE), calprotectin, club cell secretory protein (CCSP), and MMP-9, have been investigated during PEx<sup><a href="#ref-56">56</a>–<a href="#ref-59">59</a></sup>. Although most of these sputum biomarkers change significantly from stable to PEx state or following PEx treatment, the results have been variable between studies. Sputum NE appears to be promising, as a recent study by Waters <i>et al</i>. found that a decrease in sputum NE was independently associated with response to IV antibiotic treatment at day 14 and higher NE levels at day 14 were associated with greater risk of subsequent PEx<sup><a href="#ref-57">57</a></sup>.</p><p class="" id=d2492e806>Among blood biomarkers, numerous markers of inflammation have been evaluated as recently reviewed<sup><a href="#ref-60">60</a></sup>. Serum C-reactive protein (CRP) and calprotectin have been the most extensively studied in the context of PEx and offer the most promise for clinical use<sup><a href="#ref-54">54</a></sup>. All studies evaluating CRP and calprotectin in CF have demonstrated significant reductions in levels from beginning to end of PEx treatment<sup><a href="#ref-54">54</a>,<a href="#ref-56">56</a>,<a href="#ref-58">58</a></sup>. However, a recent study demonstrated that CRP increases in 25% of patients during the first 5 days of IV antibiotic treatment prior to decreasing, thus making it a challenging biomarker to monitor early response to treatment<sup><a href="#ref-61">61</a></sup>. Individuals with persistently elevated CRP and calprotectin levels following IV antibiotics also experience a shorter time to re-exacerbation<sup><a href="#ref-57">57</a>,<a href="#ref-62">62</a></sup>.</p><p class="" id=d2492e838>Although several candidate biomarkers that correlate with clinical outcomes during PEx treatment have been identified, it remains unclear whether their prospective use can influence treatment decisions to improve PEx outcomes and whether they add incremental utility to monitoring of symptoms and lung function alone.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d2492e844>Future directions</h2><p class="" id=d2492e847>Although small but incremental progress is being made in our understanding of PEx in CF on the basis of observational studies, there remain several gaps in knowledge and a need for more interventional studies to guide evidence-based practice. The CF community is eagerly awaiting the results of the aforementioned RCTs evaluating various IV antibiotic treatment durations and the adjunctive use of systemic corticosteroids and doxycycline, as these have the potential to improve PEx outcomes. In addition, a greater understanding of the sequence of events leading to a PEx at a molecular level is required to improve PEx phenotyping and to guide the development of more targeted treatments.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d2492e1 class=n-a></a><h2 class=main-title id=d2718>Competing interests</h2><p class=metadata-entry><a name=d2492e96 class=n-a></a><p id=d2492e97> No competing interests were disclosed.</p></p></div><div class=back-section><a name=d2492e1 class=n-a></a><h2 class=main-title id=d2720>Grant information</h2><p>BSQ receives salary support from the Michael Smith Foundation for Health Research and from Cystic Fibrosis Canada.</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </p></div><div class=back-section><a name=d2492e854 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d2921>References</h2><div class="section ref-list"><a name=d2492e854 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d2492e861 class=n-a></a>Cystic Fibrosis Foundation Patient Registry: 2015 Annual Report. Bethesda, Maryland. 2016 Cystic Fibrosis Foundation. <a target=xrefwindow id=d2492e863 href="https://www.cff.org/Our-Research/CF-Patient-Registry/2015-Patient-Registry-Annual-Data-Report.pdf">Reference Source</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d2492e872 class=n-a></a>Sanders DB, Bittner RC, Rosenfeld M, <i> et al.</i>: Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation. <i>Am J Respir Crit Care Med.</i> 2010; <b>182</b>(5): 627–32. <a target=xrefwindow id=d2492e883 href="http://www.ncbi.nlm.nih.gov/pubmed/20463179">PubMed Abstract </a> | <a target=xrefwindow id=d2492e886 href="http://dx.doi.org/10.1164/rccm.200909-1421OC">Publisher Full Text </a> | <a target=xrefwindow id=d2492e890 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5450763">Free Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d2492e899 class=n-a></a>Bilton D, Canny G, Conway S, <i> et al.</i>: Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials. <i>J Cyst Fibros.</i> 2011; <b>10</b>(Suppl 2): S79–81. <a target=xrefwindow id=d2492e910 href="http://www.ncbi.nlm.nih.gov/pubmed/21658647">PubMed Abstract </a> | <a target=xrefwindow id=d2492e913 href="http://dx.doi.org/10.1016/S1569-1993(11)60012-X">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d2492e922 class=n-a></a>Treggiari MM, Rosenfeld M, Mayer-Hamblett N, <i> et al.</i>: Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study'. <i>Contemp Clin Trials.</i> 2009; <b>30</b>(3): 256–68. <a target=xrefwindow id=d2492e933 href="http://www.ncbi.nlm.nih.gov/pubmed/19470318">PubMed Abstract </a> | <a target=xrefwindow id=d2492e936 href="http://dx.doi.org/10.1016/j.cct.2009.01.003">Publisher Full Text </a> | <a target=xrefwindow id=d2492e940 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2783320">Free Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727579272"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2492e949 class=n-a></a>Sanders DB, Solomon GM, Beckett VV, <i> et al.</i>: Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations. <i>J Cyst Fibros.</i> 2017; <b>16</b>(5): 592–9. <a target=xrefwindow id=d2492e960 href="http://www.ncbi.nlm.nih.gov/pubmed/28460885">PubMed Abstract </a> | <a target=xrefwindow id=d2492e963 href="http://dx.doi.org/10.1016/j.jcf.2017.04.005">Publisher Full Text </a> | <a target=xrefwindow id=d2492e967 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5582015">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727579272">F1000 Recommendation</a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731428487"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2492e981 class=n-a></a>van Horck M, Winkens B, Wesseling G, <i> et al.</i>: Early detection of pulmonary exacerbations in children with Cystic Fibrosis by electronic home monitoring of symptoms and lung function. <i>Sci Rep.</i> 2017; <b>7</b>(1): 12350. <a target=xrefwindow id=d2492e992 href="http://www.ncbi.nlm.nih.gov/pubmed/28955051">PubMed Abstract </a> | <a target=xrefwindow id=d2492e995 href="http://dx.doi.org/10.1038/s41598-017-10945-3">Publisher Full Text </a> | <a target=xrefwindow id=d2492e999 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5617859">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731428487">F1000 Recommendation</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727713701"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2492e1012 class=n-a></a>Lechtzin N, Mayer-Hamblett N, West NE, <i> et al.</i>: Home Monitoring of Patients with Cystic Fibrosis to Identify and Treat Acute Pulmonary Exacerbations. eICE Study Results. <i>Am J Respir Crit Care Med.</i> 2017; <b>196</b>(9): 1144–51. <a target=xrefwindow id=d2492e1023 href="http://www.ncbi.nlm.nih.gov/pubmed/28608719">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1026 href="http://dx.doi.org/10.1164/rccm.201610-2172OC">Publisher Full Text </a> | <a target=xrefwindow id=d2492e1030 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5694835">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727713701">F1000 Recommendation</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d2492e1043 class=n-a></a>VanDevanter DR, Elkin EP, Pasta DJ, <i> et al.</i>: Changing thresholds and incidence of antibiotic treatment of cystic fibrosis pulmonary exacerbations, 1995-2005. <i>J Cyst Fibros.</i> 2013; <b>12</b>(4): 332–7. <a target=xrefwindow id=d2492e1054 href="http://www.ncbi.nlm.nih.gov/pubmed/23273513">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1057 href="http://dx.doi.org/10.1016/j.jcf.2012.11.011">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d2492e1066 class=n-a></a>Johnson C, Butler SM, Konstan MW, <i> et al.</i>: Factors influencing outcomes in cystic fibrosis: a center-based analysis. <i>Chest.</i> 2003; <b>123</b>(1): 20–7. <a target=xrefwindow id=d2492e1077 href="http://www.ncbi.nlm.nih.gov/pubmed/12527598">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1080 href="http://dx.doi.org/10.1378/chest.123.1.20">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732042135"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2492e1089 class=n-a></a>Hoo ZH, Campbell MJ, Curley R, <i> et al.</i>: Do cystic fibrosis centres with the lowest FEV<sub>1</sub> still use the least amount of intravenous antibiotics? A registry-based comparison of intravenous antibiotic use among adult CF centres in the UK. <i>J Cyst Fibros.</i> 2017; pii: S1569-1993(17)30916-5. <a target=xrefwindow id=d2492e1100 href="http://www.ncbi.nlm.nih.gov/pubmed/29074367">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1103 href="http://dx.doi.org/10.1016/j.jcf.2017.10.005">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732042135">F1000 Recommendation</a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d2492e1116 class=n-a></a>Kraynack NC, Gothard MD, Falletta LM, <i> et al.</i>: Approach to treating cystic fibrosis pulmonary exacerbations varies widely across US CF care centers. <i>Pediatr Pulmonol.</i> 2011; <b>46</b>(9): 870–81. <a target=xrefwindow id=d2492e1127 href="http://www.ncbi.nlm.nih.gov/pubmed/21465675">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1130 href="http://dx.doi.org/10.1002/ppul.21442">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d2492e1140 class=n-a></a>Kraynack NC, McBride JT: Improving care at cystic fibrosis centers through quality improvement. <i>Semin Respir Crit Care Med.</i> 2009; <b>30</b>(5): 547–58. <a target=xrefwindow id=d2492e1148 href="http://www.ncbi.nlm.nih.gov/pubmed/19760542">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1151 href="http://dx.doi.org/10.1055/s-0029-1238913">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725997801"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2492e1160 class=n-a></a>VanDevanter DR, Morris NJ, Konstan MW: IV-treated pulmonary exacerbations in the prior year: An important independent risk factor for future pulmonary exacerbation in cystic fibrosis. <i>J Cyst Fibros.</i> 2016; <b>15</b>(3): 372–9. <a target=xrefwindow id=d2492e1168 href="http://www.ncbi.nlm.nih.gov/pubmed/26603642">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1171 href="http://dx.doi.org/10.1016/j.jcf.2015.10.006">Publisher Full Text </a> | <a target=xrefwindow id=d2492e1174 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4841746">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725997801">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726652833"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2492e1187 class=n-a></a>Stanojevic S, McDonald A, Waters V, <i> et al.</i>: Effect of pulmonary exacerbations treated with oral antibiotics on clinical outcomes in cystic fibrosis. <i>Thorax.</i> 2017; <b>72</b>(4): 327–32. <a target=xrefwindow id=d2492e1198 href="http://www.ncbi.nlm.nih.gov/pubmed/27539619">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1201 href="http://dx.doi.org/10.1136/thoraxjnl-2016-208450">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726652833">F1000 Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d2492e1214 class=n-a></a>Waters V, Atenafu EG, Salazar JG, <i> et al.</i>: Chronic <i>Stenotrophomonas maltophilia</i> infection and exacerbation outcomes in cystic fibrosis. <i>J Cyst Fibros.</i> 2012; <b>11</b>(1): 8–13. <a target=xrefwindow id=d2492e1228 href="http://www.ncbi.nlm.nih.gov/pubmed/21849265">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1232 href="http://dx.doi.org/10.1016/j.jcf.2011.07.008">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d2492e1241 class=n-a></a>Waters V, Stanojevic S, Klingel M, <i> et al.</i>: Prolongation of antibiotic treatment for cystic fibrosis pulmonary exacerbations. <i>J Cyst Fibros.</i> 2015; <b>14</b>(6): 770–6. <a target=xrefwindow id=d2492e1252 href="http://www.ncbi.nlm.nih.gov/pubmed/26265220">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1255 href="http://dx.doi.org/10.1016/j.jcf.2015.07.010">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725291956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2492e1264 class=n-a></a>Chin M, De Zoysa M, Slinger R, <i> et al.</i>: Acute effects of viral respiratory tract infections on sputum bacterial density during CF pulmonary exacerbations. <i>J Cyst Fibros.</i> 2015; <b>14</b>(4): 482–9. <a target=xrefwindow id=d2492e1275 href="http://www.ncbi.nlm.nih.gov/pubmed/25544473">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1278 href="http://dx.doi.org/10.1016/j.jcf.2014.11.009">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725291956">F1000 Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d2492e1292 class=n-a></a>Asner S, Waters V, Solomon M, <i> et al.</i>: Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosis. <i>J Cyst Fibros.</i> 2012; <b>11</b>(5): 433–9. <a target=xrefwindow id=d2492e1303 href="http://www.ncbi.nlm.nih.gov/pubmed/22579414">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1306 href="http://dx.doi.org/10.1016/j.jcf.2012.04.006">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d2492e1315 class=n-a></a>Wat D, Gelder C, Hibbitts S, <i> et al.</i>: The role of respiratory viruses in cystic fibrosis. <i>J Cyst Fibros.</i> 2008; <b>7</b>(4): 320–8. <a target=xrefwindow id=d2492e1326 href="http://www.ncbi.nlm.nih.gov/pubmed/18255355">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1329 href="http://dx.doi.org/10.1016/j.jcf.2007.12.002">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d2492e1338 class=n-a></a>Goffard A, Lambert V, Salleron J, <i> et al.</i>: Virus and cystic fibrosis: rhinoviruses are associated with exacerbations in adult patients. <i>J Clin Virol.</i> 2014; <b>60</b>(2): 147–53. <a target=xrefwindow id=d2492e1349 href="http://www.ncbi.nlm.nih.gov/pubmed/24637203">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1352 href="http://dx.doi.org/10.1016/j.jcv.2014.02.005">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727429805"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2492e1361 class=n-a></a>Somayaji R, Goss CH, Khan U, <i> et al.</i>: Cystic Fibrosis Pulmonary Exacerbations Attributable to Respiratory Syncytial Virus and Influenza: A Population-Based Study. <i>Clin Infect Dis.</i> 2017; <b>64</b>(12): 1760–7. <a target=xrefwindow id=d2492e1372 href="http://www.ncbi.nlm.nih.gov/pubmed/28329304">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1375 href="http://dx.doi.org/10.1093/cid/cix203">Publisher Full Text </a> | <a target=xrefwindow id=d2492e1379 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5848232">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727429805">F1000 Recommendation</a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d2492e1392 class=n-a></a>Hendricks MR, Lashua LP, Fischer DK, <i> et al.</i>: Respiratory syncytial virus infection enhances <i>Pseudomonas aeruginosa</i> biofilm growth through dysregulation of nutritional immunity. <i>Proc Natl Acad Sci U S A.</i> 2016; <b>113</b>(6): 1642–7. <a target=xrefwindow id=d2492e1406 href="http://www.ncbi.nlm.nih.gov/pubmed/26729873">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1410 href="http://dx.doi.org/10.1073/pnas.1516979113">Publisher Full Text </a> | <a target=xrefwindow id=d2492e1413 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4760822">Free Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d2492e1422 class=n-a></a>de Almeida MB, Zerbinati RM, Tateno AF, <i> et al.</i>: Rhinovirus C and respiratory exacerbations in children with cystic fibrosis. <i>Emerg Infect Dis.</i> 2010; <b>16</b>(6): 996–9. <a target=xrefwindow id=d2492e1433 href="http://www.ncbi.nlm.nih.gov/pubmed/20507756">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1436 href="http://dx.doi.org/10.3201/eid1606.100063">Publisher Full Text </a> | <a target=xrefwindow id=d2492e1440 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3086221">Free Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d2492e1450 class=n-a></a>Stelzer-Braid S, Johal H, Skilbeck K, <i> et al.</i>: Detection of viral and bacterial respiratory pathogens in patients with cystic fibrosis. <i>J Virol Methods.</i> 2012; <b>186</b>(1–2): 109–12. <a target=xrefwindow id=d2492e1461 href="http://www.ncbi.nlm.nih.gov/pubmed/22940004">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1464 href="http://dx.doi.org/10.1016/j.jviromet.2012.08.008">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d2492e1473 class=n-a></a>Stressmann FA, Rogers GB, Marsh P, <i> et al.</i>: Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation? <i>J Cyst Fibros.</i> 2011; <b>10</b>(5): 357–65. <a target=xrefwindow id=d2492e1484 href="http://www.ncbi.nlm.nih.gov/pubmed/21664196">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1487 href="http://dx.doi.org/10.1016/j.jcf.2011.05.002">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d2492e1496 class=n-a></a>Carmody LA, Zhao J, Schloss PD, <i> et al.</i>: Changes in cystic fibrosis airway microbiota at pulmonary exacerbation. <i>Ann Am Thorac Soc.</i> 2013; <b>10</b>(3): 179–87. <a target=xrefwindow id=d2492e1507 href="http://www.ncbi.nlm.nih.gov/pubmed/23802813">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1510 href="http://dx.doi.org/10.1513/AnnalsATS.201211-107OC">Publisher Full Text </a> | <a target=xrefwindow id=d2492e1514 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3960905">Free Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d2492e1523 class=n-a></a>Fothergill JL, Ledson MJ, Walshaw MJ, <i> et al.</i>: Comparison of real time diagnostic chemistries to detect <i>Pseudomonas aeruginosa</i> in respiratory samples from cystic fibrosis patients. <i>J Cyst Fibros.</i> 2013; <b>12</b>(6): 675–81. <a target=xrefwindow id=d2492e1537 href="http://www.ncbi.nlm.nih.gov/pubmed/23726365">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1541 href="http://dx.doi.org/10.1016/j.jcf.2013.04.007">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725462707"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2492e1550 class=n-a></a>Lam JC, Somayaji R, Surette MG, <i> et al.</i>: Reduction in <i>Pseudomonas aeruginosa</i> sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response. <i>BMC Infect Dis.</i> 2015; <b>15</b>: 145. <a target=xrefwindow id=d2492e1564 href="http://www.ncbi.nlm.nih.gov/pubmed/25887462">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1568 href="http://dx.doi.org/10.1186/s12879-015-0856-5">Publisher Full Text </a> | <a target=xrefwindow id=d2492e1571 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4392784">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725462707">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1017300"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2492e1584 class=n-a></a>Ordoñez CL, Henig NR, Mayer-Hamblett N, <i> et al.</i>: Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis. <i>Am J Respir Crit Care Med.</i> 2003; <b>168</b>(12): 1471–5. <a target=xrefwindow id=d2492e1595 href="http://www.ncbi.nlm.nih.gov/pubmed/12969869">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1598 href="http://dx.doi.org/10.1164/rccm.200306-731OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1017300">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d2492e1612 class=n-a></a>Tunney MM, Klem ER, Fodor AA, <i> et al.</i>: Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis. <i>Thorax.</i> 2011; <b>66</b>(7): 579–84. <a target=xrefwindow id=d2492e1623 href="http://www.ncbi.nlm.nih.gov/pubmed/21270069">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1626 href="http://dx.doi.org/10.1136/thx.2010.137281">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d2492e1635 class=n-a></a>Nicod LP, Kolls JK: Chair's Summary: Mechanisms of Exacerbation of Lung Diseases. <i>Ann Am Thorac Soc.</i> 2015; <b>12 Suppl 2</b>: S112–4. <a target=xrefwindow id=d2492e1643 href="http://www.ncbi.nlm.nih.gov/pubmed/26595726">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1646 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4722835">Free Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d2492e1655 class=n-a></a>Goss CH, Newsom SA, Schildcrout JS, <i> et al.</i>: Effect of ambient air pollution on pulmonary exacerbations and lung function in cystic fibrosis. <i>Am J Respir Crit Care Med.</i> 2004; <b>169</b>(7): 816–21. <a target=xrefwindow id=d2492e1666 href="http://www.ncbi.nlm.nih.gov/pubmed/14718248">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1669 href="http://dx.doi.org/10.1164/rccm.200306-779OC">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d2492e1678 class=n-a></a>Goeminne PC, Kiciński M, Vermeulen F, <i> et al.</i>: Impact of air pollution on cystic fibrosis pulmonary exacerbations: a case-crossover analysis. <i>Chest.</i> 2013; <b>143</b>(4): 946–54. <a target=xrefwindow id=d2492e1689 href="http://www.ncbi.nlm.nih.gov/pubmed/23081770">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1692 href="http://dx.doi.org/10.1378/chest.12-1005">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d2492e1701 class=n-a></a>Stenbit AE, Flume PA: Pulmonary exacerbations in cystic fibrosis. <i>Curr Opin Pulm Med.</i> 2011; <b>17</b>(6): 442–7. <a target=xrefwindow id=d2492e1709 href="http://www.ncbi.nlm.nih.gov/pubmed/21881509">PubMed Abstract </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727569176"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2492e1718 class=n-a></a>West NE, Beckett VV, Jain R, <i> et al.</i>: Standardized Treatment of Pulmonary Exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary Exacerbations. <i>J Cyst Fibros.</i> 2017; <b>16</b>(5): 600–6. <a target=xrefwindow id=d2492e1729 href="http://www.ncbi.nlm.nih.gov/pubmed/28457954">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1732 href="http://dx.doi.org/10.1016/j.jcf.2017.04.003">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727569176">F1000 Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d2492e1746 class=n-a></a>Waters V, Ratjen F: Pulmonary Exacerbations in Children with Cystic Fibrosis. <i>Ann Am Thorac Soc.</i> 2015; <b>12 Suppl 2</b>: S200–6. <a target=xrefwindow id=d2492e1754 href="http://www.ncbi.nlm.nih.gov/pubmed/26595740">PubMed Abstract </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d2492e1763 class=n-a></a>Goss CH, Edwards TC, Ramsey BW, <i> et al.</i>: Patient-reported respiratory symptoms in cystic fibrosis. <i>J Cyst Fibros.</i> 2009; <b>8</b>(4): 245–52. <a target=xrefwindow id=d2492e1774 href="http://www.ncbi.nlm.nih.gov/pubmed/19481983">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1777 href="http://dx.doi.org/10.1016/j.jcf.2009.04.003">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d2492e1786 class=n-a></a>Goss CH, Caldwell E, Gries KNL, <i> et al.</i>: Validation of a novel patient-reported respiratory symptoms instrument in cystic fibrosis: CFRSD-CRISS. <i>Pediatr Pulmonol.</i> 2013: A251. </span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725449757"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2492e1801 class=n-a></a>Heltshe SL, Goss CH, Thompson V, <i> et al.</i>: Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis. <i>Thorax.</i> 2016; <b>71</b>(3): 223–9. <a target=xrefwindow id=d2492e1812 href="http://www.ncbi.nlm.nih.gov/pubmed/25911223">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1815 href="http://dx.doi.org/10.1136/thoraxjnl-2014-206750">Publisher Full Text </a> | <a target=xrefwindow id=d2492e1819 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4778725">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725449757">F1000 Recommendation</a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d2492e1832 class=n-a></a>Flume PA, Mogayzel PJ Jr, Robinson KA, <i> et al.</i>: Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations. <i>Am J Respir Crit Care Med.</i> 2009; <b>180</b>(9): 802–8. <a target=xrefwindow id=d2492e1843 href="http://www.ncbi.nlm.nih.gov/pubmed/19729669">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1846 href="http://dx.doi.org/10.1164/rccm.200812-1845PP">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d2492e1855 class=n-a></a>Wolter JM, Bowler SD, Nolan PJ, <i> et al.</i>: Home intravenous therapy in cystic fibrosis: a prospective randomized trial examining clinical, quality of life and cost aspects. <i>Eur Respir J.</i> 1997; <b>10</b>(4): 896–900. <a target=xrefwindow id=d2492e1866 href="http://www.ncbi.nlm.nih.gov/pubmed/9150331">PubMed Abstract </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d2492e1876 class=n-a></a>Nazer D, Abdulhamid I, Thomas R, <i> et al.</i>: Home versus hospital intravenous antibiotic therapy for acute pulmonary exacerbations in children with cystic fibrosis. <i>Pediatr Pulmonol.</i> 2006; <b>41</b>(8): 744–9. <a target=xrefwindow id=d2492e1887 href="http://www.ncbi.nlm.nih.gov/pubmed/16779852">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1890 href="http://dx.doi.org/10.1002/ppul.20433">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727450217"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2492e1899 class=n-a></a>Morgan WJ, Wagener JS, Pasta DJ, <i> et al.</i>: Relationship of Antibiotic Treatment to Recovery after Acute FEV<sub>1</sub> Decline in Children with Cystic Fibrosis. <i>Ann Am Thorac Soc.</i> 2017; <b>14</b>(6): 937–42. <a target=xrefwindow id=d2492e1913 href="http://www.ncbi.nlm.nih.gov/pubmed/28324670">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1917 href="http://dx.doi.org/10.1513/AnnalsATS.201608-615OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727450217">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732119423"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2492e1930 class=n-a></a>Schechter MS, VanDevanter DR, Pasta DJ, <i> et al.</i>: Treatment Setting and Outcomes of Cystic Fibrosis Pulmonary Exacerbations. <i>Ann Am Thorac Soc.</i> 2018; <b>15</b>(2): 225–33. <a target=xrefwindow id=d2492e1941 href="http://www.ncbi.nlm.nih.gov/pubmed/29140726">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1944 href="http://dx.doi.org/10.1513/AnnalsATS.201702-111OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732119423">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/7241961"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2492e1957 class=n-a></a>Collaco JM, Green DM, Cutting GR, <i> et al.</i>: Location and duration of treatment of cystic fibrosis respiratory exacerbations do not affect outcomes. <i>Am J Respir Crit Care Med.</i> 2010; <b>182</b>(9): 1137–43. <a target=xrefwindow id=d2492e1968 href="http://www.ncbi.nlm.nih.gov/pubmed/20581166">PubMed Abstract </a> | <a target=xrefwindow id=d2492e1971 href="http://dx.doi.org/10.1164/rccm.201001-0057OC">Publisher Full Text </a> | <a target=xrefwindow id=d2492e1975 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3001256">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/7241961">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732190059"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2492e1988 class=n-a></a>Heltshe SL, West NE, VanDevanter DR, <i> et al.</i>: Study design considerations for the Standardized Treatment of Pulmonary Exacerbations 2 (STOP<sub>2</sub>): A trial to compare intravenous antibiotic treatment durations in CF. <i>Contemp Clin Trials.</i> 2018; <b>64</b>: 35–40. <a target=xrefwindow id=d2492e2002 href="http://www.ncbi.nlm.nih.gov/pubmed/29170074">PubMed Abstract </a> | <a target=xrefwindow id=d2492e2006 href="http://dx.doi.org/10.1016/j.cct.2017.11.012">Publisher Full Text </a> | <a target=xrefwindow id=d2492e2009 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5742044">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732190059">F1000 Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727246943"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2492e2022 class=n-a></a>Cogen JD, Oron AP, Gibson RL, <i> et al.</i>: Characterization of Inpatient Cystic Fibrosis Pulmonary Exacerbations. <i>Pediatrics.</i> 2017; <b>139</b>(2). pii: e20162642. <a target=xrefwindow id=d2492e2033 href="http://www.ncbi.nlm.nih.gov/pubmed/28126911">PubMed Abstract </a> | <a target=xrefwindow id=d2492e2036 href="http://dx.doi.org/10.1542/peds.2016-2642">Publisher Full Text </a> | <a target=xrefwindow id=d2492e2040 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5472380">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727246943">F1000 Recommendation</a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/11399"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2492e2054 class=n-a></a>Elkins MR, Robinson M, Rose BR, <i> et al.</i>: A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. <i>N Engl J Med.</i> 2006; <b>354</b>(3): 229–40. <a target=xrefwindow id=d2492e2065 href="http://www.ncbi.nlm.nih.gov/pubmed/16421364">PubMed Abstract </a> | <a target=xrefwindow id=d2492e2068 href="http://dx.doi.org/10.1056/NEJMoa043900">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/11399">F1000 Recommendation</a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726080765"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2492e2081 class=n-a></a>Dentice RL, Elkins MR, Middleton PG, <i> et al.</i>: A randomised trial of hypertonic saline during hospitalisation for exacerbation of cystic fibrosis. <i>Thorax.</i> 2016; <b>71</b>(2): 141–7. <a target=xrefwindow id=d2492e2092 href="http://www.ncbi.nlm.nih.gov/pubmed/26769016">PubMed Abstract </a> | <a target=xrefwindow id=d2492e2095 href="http://dx.doi.org/10.1136/thoraxjnl-2014-206716">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726080765">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d2492e2108 class=n-a></a>Gaggar A, Li Y, Weathington N, <i> et al.</i>: Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients. <i>Am J Physiol Lung Cell Mol Physiol.</i> 2007; <b>293</b>(1): L96–L104. <a target=xrefwindow id=d2492e2119 href="http://www.ncbi.nlm.nih.gov/pubmed/17384080">PubMed Abstract </a> | <a target=xrefwindow id=d2492e2122 href="http://dx.doi.org/10.1152/ajplung.00492.2006">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d2492e2131 class=n-a></a>Hanemaaijer R, Visser H, Koolwijk P, <i> et al.</i>: Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells. <i>Adv Dent Res.</i> 1998; <b>12</b>(2): 114–8. <a target=xrefwindow id=d2492e2142 href="http://www.ncbi.nlm.nih.gov/pubmed/9972133">PubMed Abstract </a> | <a target=xrefwindow id=d2492e2145 href="http://dx.doi.org/10.1177/08959374980120010301">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727484307"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2492e2154 class=n-a></a>Xu X, Abdalla T, Bratcher PE, <i> et al.</i>: Doxycycline improves clinical outcomes during cystic fibrosis exacerbations. <i>Eur Respir J.</i> 2017; <b>49</b>(4): pii: 1601102. <a target=xrefwindow id=d2492e2165 href="http://www.ncbi.nlm.nih.gov/pubmed/28381428">PubMed Abstract </a> | <a target=xrefwindow id=d2492e2168 href="http://dx.doi.org/10.1183/13993003.01102-2016">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727484307">F1000 Recommendation</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1089466"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2492e2181 class=n-a></a>Dovey M, Aitken ML, Emerson J, <i> et al.</i>: Oral corticosteroid therapy in cystic fibrosis patients hospitalized for pulmonary exacerbation: a pilot study. <i>Chest.</i> 2007; <b>132</b>(4): 1212–8. <a target=xrefwindow id=d2492e2192 href="http://www.ncbi.nlm.nih.gov/pubmed/17646219">PubMed Abstract </a> | <a target=xrefwindow id=d2492e2195 href="http://dx.doi.org/10.1378/chest.07-0843">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1089466">F1000 Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d2492e2209 class=n-a></a>Shoki AH, Mayer-Hamblett N, Wilcox PG, <i> et al.</i>: Systematic review of blood biomarkers in cystic fibrosis pulmonary exacerbations. <i>Chest.</i> 2013; <b>144</b>(5): 1659–70. <a target=xrefwindow id=d2492e2220 href="http://www.ncbi.nlm.nih.gov/pubmed/23868694">PubMed Abstract </a> | <a target=xrefwindow id=d2492e2223 href="http://dx.doi.org/10.1378/chest.13-0693">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d2492e2232 class=n-a></a>Sagel SD, Chmiel JF, Konstan MW: Sputum biomarkers of inflammation in cystic fibrosis lung disease. <i>Proc Am Thorac Soc.</i> 2007; <b>4</b>(4): 406–17. <a target=xrefwindow id=d2492e2240 href="http://www.ncbi.nlm.nih.gov/pubmed/17652508">PubMed Abstract </a> | <a target=xrefwindow id=d2492e2243 href="http://dx.doi.org/10.1513/pats.200703-044BR">Publisher Full Text </a> | <a target=xrefwindow id=d2492e2246 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2647605">Free Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d2492e2255 class=n-a></a>Horsley AR, Davies JC, Gray RD, <i> et al.</i>: Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation. <i>Thorax.</i> 2013; <b>68</b>(6): 532–9. <a target=xrefwindow id=d2492e2266 href="http://www.ncbi.nlm.nih.gov/pubmed/23396354">PubMed Abstract </a> | <a target=xrefwindow id=d2492e2269 href="http://dx.doi.org/10.1136/thoraxjnl-2012-202538">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725359081"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2492e2278 class=n-a></a>Waters VJ, Stanojevic S, Sonneveld N, <i> et al.</i>: Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients. <i>J Cyst Fibros.</i> 2015; <b>14</b>(6): 755–62. <a target=xrefwindow id=d2492e2289 href="http://www.ncbi.nlm.nih.gov/pubmed/25690407">PubMed Abstract </a> | <a target=xrefwindow id=d2492e2292 href="http://dx.doi.org/10.1016/j.jcf.2015.01.007">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725359081">F1000 Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d2492e2305 class=n-a></a>Gray RD, Imrie M, Boyd AC, <i> et al.</i>: Sputum and serum calprotectin are useful biomarkers during CF exacerbation. <i>J Cyst Fibros.</i> 2010; <b>9</b>(3): 193–8. <a target=xrefwindow id=d2492e2316 href="http://www.ncbi.nlm.nih.gov/pubmed/20299288">PubMed Abstract </a> | <a target=xrefwindow id=d2492e2319 href="http://dx.doi.org/10.1016/j.jcf.2010.01.005">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d2492e2328 class=n-a></a>Laguna TA, Williams CB, Brandy KR, <i> et al.</i>: Sputum club cell protein concentration is associated with pulmonary exacerbation in cystic fibrosis. <i>J Cyst Fibros.</i> 2015; <b>14</b>(3): 334–40. <a target=xrefwindow id=d2492e2339 href="http://www.ncbi.nlm.nih.gov/pubmed/25456770">PubMed Abstract </a> | <a target=xrefwindow id=d2492e2342 href="http://dx.doi.org/10.1016/j.jcf.2014.10.002">Publisher Full Text </a> | <a target=xrefwindow id=d2492e2346 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4408227">Free Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727737175"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d2492e2356 class=n-a></a>Scott LK, Toner R: Clinically Promising Biomarkers in Cystic Fibrosis Pulmonary Exacerbations. <i>Lung.</i> 2017; <b>195</b>(4): 397–401. <a target=xrefwindow id=d2492e2364 href="http://www.ncbi.nlm.nih.gov/pubmed/28623538">PubMed Abstract </a> | <a target=xrefwindow id=d2492e2367 href="http://dx.doi.org/10.1007/s00408-017-0024-3">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727737175">F1000 Recommendation</a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d2492e2380 class=n-a></a>Sharma A, Kirkpatrick G, Chen V, <i> et al.</i>: Clinical utility of C-reactive protein to predict treatment response during cystic fibrosis pulmonary exacerbations. <i>PLoS One.</i> 2017; <b>12</b>(2): e0171229. <a target=xrefwindow id=d2492e2391 href="http://www.ncbi.nlm.nih.gov/pubmed/28178305">PubMed Abstract </a> | <a target=xrefwindow id=d2492e2394 href="http://dx.doi.org/10.1371/journal.pone.0171229">Publisher Full Text </a> | <a target=xrefwindow id=d2492e2398 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5298271">Free Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d2492e2407 class=n-a></a>Parkins MD, Rendall JC, Elborn JS: Incidence and risk factors for pulmonary exacerbation treatment failures in patients with cystic fibrosis chronically infected with <i>Pseudomonas aeruginosa</i>. <i>Chest.</i> 2012; <b>141</b>(2): 485–93. <a target=xrefwindow id=d2492e2418 href="http://www.ncbi.nlm.nih.gov/pubmed/21835906">PubMed Abstract </a> | <a target=xrefwindow id=d2492e2421 href="http://dx.doi.org/10.1378/chest.11-0917">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 14 May 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-575.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-575.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Division of Respirology, Department of Medicine, University of Calgary, Calgary, AB, Canada<br/> <sup>2</sup> Centre for Heart Lung Innovation, St Paul&rsquo;s Hospital, Department of Medicine, University of British Columbia, Vancouver, BC, Canada<br/> <p> <div class=margin-bottom> Kate Skolnik <br/> <span>Roles: </span> Conceptualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Bradley S. Quon <br/> <span>Roles: </span> Conceptualization, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-575/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 14 May 2018, 7:575 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.13926.1">https://doi.org/10.12688/f1000research.13926.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2018 Skolnik K and Quon BS. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=15139 data-id=13926 data-downloads="" data-views="" data-scholar="10.12688/f1000research.13926.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-575/v1/pdf?article_uuid=ec0a8c35-f7b2-457c-81d1-c31c651223fa" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.13926.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Skolnik K and Quon BS. Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations [version 1; peer review: 3 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):575 (<a href="https://doi.org/10.12688/f1000research.13926.1" target=_blank>https://doi.org/10.12688/f1000research.13926.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=13926 id=mobile-track-article-signin-13926 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/13926?target=/articles/7-575.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=15139 /> <input name=articleId type=hidden value=13926 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>John J LiPuma</strong>, Department of Pediatrics and Communicable Diseases, University of Michigan Medical School, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Martin J Wildman</strong>, School of Health and Related Research (ScHARR), University of Sheffield, UK </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Patrick A. Flume</strong>, Department of Medicine and Pediatrics, Medical University of South Carolina, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 14 May 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-575.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-575.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=34269-33849></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=34268-33847></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=28992-33850></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=3><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-575/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>14 May 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>John J LiPuma</strong>, Department of Pediatrics and Communicable Diseases, University of Michigan Medical School, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Martin J Wildman</strong>, School of Health and Related Research (ScHARR), University of Sheffield, UK </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Patrick A. Flume</strong>, Department of Medicine and Pediatrics, Medical University of South Carolina, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-575.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-575/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in the understanding and...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-575/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-575/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-575/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Skolnik K and Quon BS');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-575/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-575",
            templates : {
                twitter : "Recent advances in the understanding and management of cystic.... Skolnik K and Quon BS, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-575/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/13926/15139")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "15139");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "33847": 0,
                           "33848": 0,
                           "33849": 0,
                           "33850": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "254c96eb-277a-4421-af5e-1c9f380ce6a7";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-575.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-575.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-575.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-575.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-575.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>